Status:
COMPLETED
Electronic Recording of Compliance With Occlusion Therapy for Amblyopia
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Albert von Metzler Foundation
Conditions:
Amblyopia
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The purpose of this study was to determine whether compliance with occlusion therapy for amblyopia could be improved and, secondly, if risk factors for non-compliance could be identified.
Detailed Description
Non-compliance is a limiting factor for success of occlusion therapy for amblyopia (lazy eye) in childhood. It is responsible for approximately 1% of the adult population being unable to read with the...
Eligibility Criteria
Inclusion
- All newly diagnosed amblyopic children with an inter-ocular difference in visual acuity of at least 0.2 logMAR, strabismus and/or anisometropia or deprivation (e.g. cataract)
Exclusion
- Previous treatment for amblyopia
- Neurological disorder
- Medication
- Other eye disorder
- Decreased visual acuity caused by brain damage or trauma
Key Trial Info
Start Date :
July 1 2001
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00131729
Start Date
July 1 2001
End Date
December 1 2005
Last Update
March 20 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitäts-Augenklinik Frankfurt
Frankfurt am Main, Germany, 60590
2
Leicester Royal Infirmary; Dept. of Ophthalmology
Leicester, United Kingdom, LE2 7LX